mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.004 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.004 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.005 |